Icon

FIRVANQ KIT (nda208910)- (EQ 25MG BASE/ML,EQ 50MG BASE/ML)

VANCOMYCIN HYDROCHLORIDE AZURITY
EQ 25MG BASE/ML,EQ 50MG BASE/ML
Yes Yes
2035-Mar-13 Expired
None None
None No
FIRVANQ is a glycopeptide antibacterial indicated in adults and pediatric patients less than 18 years of age for the treatment of: • Clostridium difficile-associated diarrhea • Enterocolitis caused by Staphylococcus aureus (including methicillin-resistant strains).
1 0 1
Total Other Developers None
Drugs with Suitability No
EQ 25MG BASE/ML ** ** - - 1
EQ 50MG BASE/ML ** ** Up - 1
NDA Sales Available Total Generic Sales Available
Yes 1
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** **** *** ***** ************ ******* *********** **** **. ***/*, ***, ***/*, ***/* & ***/* ******* ****** ***** *****, *******, *****, ***** & *** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.